论文部分内容阅读
目的观察丹灯通脑软胶囊联合阿托伐他汀治疗高脂血症的临床疗效。方法将187例原发性高血脂患者随机分为治疗组和对照组,治疗组(n=98)给予丹灯通脑软胶囊联合阿托伐他汀治疗,对照组(n=89)给予单独使用阿托伐他汀治疗,4周为1个疗程,比较1个疗程后,两组的血脂水平变化情况及疗效。结果治疗后两组的TC、TG、LDL-C、HDL-C比较,治疗组明显优于对照组,两组比较差异均有统计学意义(P均<0.05);治疗组的总有效率(97.96%)明显高于对照组(80.90%),两组比较差异具有统计学意义(P<0.05)。结论使用丹灯通脑软胶囊联合阿托伐他汀治疗原发性高血脂疗效确切,具有临床推广的意义。
Objective To observe the clinical efficacy of Dan Deng Tong Nao Soft Capsule combined with atorvastatin in the treatment of hyperlipidemia. Methods 187 patients with primary hyperlipidemia were randomly divided into treatment group and control group. The treatment group (n = 98) was treated with Dan Deng Tong Nao Soft Capsule combined with atorvastatin. The control group (n = 89) Atorvastatin treatment, 4 weeks for a course of treatment, after a course of treatment, the two groups of blood lipid levels and efficacy. Results Compared with control group, TC, TG, LDL-C and HDL-C in the two groups after treatment were significantly better than those in the control group (P <0.05). The total effective rate 97.96%) was significantly higher than the control group (80.90%), the difference between the two groups was statistically significant (P <0.05). Conclusion The use of Dan Deng Tong brain soft capsule combined with atorvastatin treatment of primary hyperlipidemia exact effect of clinical promotion.